| Identification | Back Directory | [Name]
4-Piperidinecarboxylic acid, 1-[(3-chloro-2-fluorophenyl)methyl]-4-[[3-fluoro-4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyridinyl]methyl]-2-methyl-, (2R,4R)- | [CAS]
2677799-04-9 | [Synonyms]
Aurora A inhibitor 1
4-Piperidinecarboxylic acid, 1-[(3-chloro-2-fluorophenyl)methyl]-4-[[3-fluoro-4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyridinyl]methyl]-2-methyl-, (2R,4R)- | [Molecular Formula]
C25H28ClF2N5O2 | [MOL File]
2677799-04-9.mol | [Molecular Weight]
503.97 |
| Hazard Information | Back Directory | [Uses]
Aurora A inhibitor 1 is a potent and selective inhibitor of Aurora A. Aurora A has been implicated in cancers of diverse histological origin and may possess oncogenic properties when overexpressed. Aurora A inhibitor 1 has the potential for the research of cancer diseases mediated by aurora a (extracted from patent WO2021147974A1, compound 49)[1]. | [References]
[1] Dai Cheng, et al. Novel heterocyclic compounds useful as aurora a selective inhibitors. Patent WO2021147974A1. |
|
|